Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | +2.79% | -1.53% | -1.43% |
04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
03-29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.43% | 19.43M | |
+30.38% | 684B | |
+29.18% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.89% | 240B | |
+9.14% | 208B | |
-7.65% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Wedbush Cuts Kala Pharmaceuticals' Price Target to $39 From $42, Maintains Outperform Rating